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Abstract Pax4 belongs to the paired-box family of
transcription factors. The analysis of loss- and gain-of-
function mutant animals revealed that this factor plays
a crucial role in the endocrine pancreas. Indeed, Pax4
is required for the genesis of insulin-producing beta-
cells. Remarkably, the sole misexpression of Pax4 in
glucagon-expressing cells is able to induce their
regeneration, endow these with beta-cell features,
and thereby counter chemically induced diabetes.
However, the function of Pax4 in adult endocrine cells
remains unclear. Herein, we report the generation of
Pax4 conditional knockout mice that will allow the
analysis of Pax4 function in mature beta-cells, as well
as in the adult central nervous system.
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Introduction
Pax4 is a member of the paired-box-containing family
of transcription factors (Mansouri et al. 1996) that has
been shown to play a crucial role in the endocrine
pancreas (Sosa-Pineda et al. 1997). During pancreas
morphogenesis, Pax4 is first detected in the pancreatic
epithelium and is later found confined to developing
insulin-producing beta-cells, where it is down-regu-
lated perinatally. Cell-lineage studies revealed an
expression of Pax4 in all endocrine precursors
(Greenwood et al. 2007). Importantly, the analysis of
the pancreas of Pax4-deficient animals demonstrated
that this factor is an important player in the processes
underlying beta-cell genesis (Sosa-Pineda et al. 1997).
Indeed, in the absence of Pax4 gene activity, while
mutant islets display normal morphology and cell
counts, a dramatic beta- and delta-cell loss and a
proportional increase in the glucagon-producing
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alpha-cell content are evident (Sosa-Pineda et al.
1997). Further studies have evidenced that, during
endocrine cell genesis, Pax4 is involved in the
endocrine cell subtype specification. During this
process, Pax4 and Arx undergo a reciprocal cross-
inhibitory interaction to endow endocrine progenitors
with beta- and alpha-cell destiny, respectively (Col-
lombat et al. 2003; Collombat et al. 2006). Arx is a
homeobox-containing transcription factor that is
required for the formation of glucagon-producing
alpha-cells (Collombat et al. 2003). Additionally,
compound mutants for Pax4 and Arx suffer from a loss
of beta- and alpha-cells while the delta-cell content is
augmented, revealing that Pax4 is not required for
delta-cell genesis (Collombat et al. 2005). Remark-
ably, the forced expression of Pax4 in glucagon? cells
Fig. 1 Targeting construct. The targeting construct was
designed and genetic manipulations were performed using
recombineering techniques (Copeland et al. 2001). Briefly, a
LoxP site was introduced within the first intron and the
neomycin resistance cassette carrying the second LoxP site
and flanked by Frt sites within the sixth intron. 129 Bac DNA
spanning the mouse Pax4 locus was used to isolate the
sequences required for the cloning of the targeting construct
(A). For negative selection, a MCI-TK cassette was added at the
30end to allow selection with gancyclivir (Mansour et al. 1988).
The size of the 50and 30 homology arms (HA) is indicated.
Internal and external probes as well as the location of primers for
PCR genotyping are also shown. Black boxes indicate exons.
White arrowheads represent FRT-sites and dark arrowheads
LoxP-sites. B Genomic Southern-blot using 50 and 30 external,
as well as internal probe; N: Nde1; S: Spe1; E: EcoRI, genotype
is indicated: ?/? wild type; ± heterozygous for the floxed
allele. C Genotyping by PCR; M: molecular weight marker;
?/? wild type; fl/? heterozygous and fl/fl: homozygous
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in vivo was found to induce their regeneration and
subsequent conversion into functional beta-like cells
that can counter chemically-induced diabetes (Col-
lombat et al. 2009). Hence, Pax4 appears both
necessary and sufficient to promote the beta-cell
fate/phenotype. However, despite such important
roles, the function of this factor in adult beta-cells
has hitherto not been addressed. Studies using human
and rat islets suggested that it might play an important
role in beta-cell proliferation and survival in the adult
pancreas (Brun et al. 2004). In addition, the overex-
pression of Pax4 in adult beta-cells appears to protect
insulin-producing cells from apoptosis (Hu He et al.
2011). We therefore used an embryonic stem cell-
mediated gene targeting approach to generate Pax4
conditional knockout mice.
Materials and methods
Generation of Pax4 conditional knockout mice
Using the recombineering approach (http://recombin
eering.ncifcrf.gov/Plasmid.asp), a Pax4 targeting
construct was generated. Specifically, one LoxP site
was inserted within the first intron, and a neomycin
resistance cassette was introduced within the sixth
intron (Fig. 1). The neomycin resistance coding
sequences are under the control of the PGK promoter.
This cassette is flanked by FRT sites and followed by
one LoxP-site (Fig. 1A). The thymidine kinase gene,
used for negative selection, was inserted at the 30end
of the construct. The targeting construct was electro-
porated in MPI II ES cells and targeted clones
were identified by Southern blot (Fig. 1B). Germ line
chimeras were generated by morulae aggregation.
Two independent ES cell lines gave germ line trans-
mission. Genotyping reactions were performed using
PCR (Primer pair 1: 50-AGCTCCAGTGAGTTTA
GAAACTGCTAGGAGGTG-30 and 50-CTTCCTC
AAGTGGGCAACTTGACATCTGGCCCA-30—WT
allele: 358 bp; CKO allele: 466 bp; Primer pair 2:
50-GTCTTGAGACTTATGGGTGAAGGCTGACAG
GGTCC-30 and 50-CAGTATACATTCGTCTCCTTTA
CAGACCCTCACAC-30—WT allele: 304 bp; P4CKO
Allele: 417 bp). Animal care and experimental use
were approved by the Ministry of Agriculture of Low
Saxony (LAVES), Germany.
Immunohistochemistry
Embryos were prepared at the indicated time points
and pancreatic tissues were isolated and transferred for
fixation in 4 % paraformaldehyde overnight. After
dehydration, the tissues were embedded in paraffin
and 8 lm sections were prepared. Following several
washes in PBS for 5 min, sections were transferred
into blocking solution consisting of PBS containing
10 % fetal calf serum for 1 h. Primary antibodies were
diluted in the same blocking solution and incubated
Fig. 2 Inactivation of Pax4 in animals harboring a Pax4 floxed
allele and CMV-Cre transgene. Section of E15.5 pancreas
derived from Pax4 fl/? (A) and CMV-Cre::Pax4 fl/LacZ (B) mice
stained for Pax4 (red) and Pax6 (green). In CMVCre::Pax4 fl/LacZ
mutants, the expression of Pax4 is clearly abolished (B)
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overnight at 4 C. Following washes in PBS, the slides
were treated for 1 h with the corresponding secondary
antibodies diluted into PBS containing 10 % fetal calf
serum. Slides were then rinsed with PBS, mounted
with DAPI, and analyzed by fluorescence microscopy.
Primary antibodies used: mouse anti Pax6 (Develop-
mental Studies Hybridoma Bank, dshb@uiowa.edu
1:50), Rabbit anti Pax4 (1:500), kindly provided by
Dr. Sosa-Pineda (Collombat et al. 2009); guinea pig
anti insulin (1:1000, Dako), mouse anti glucagon
(1:1000, abcam), rabbit anti somatostatin (1:600,
Dako), rabbit anti ghrelin (1:1000, Millipore), goat
anti ghrelin (1:50, Santa Cruz). The secondary anti-
bodies (1/1000, Molecular Probes) used : 594-alexa
anti-mouse, 488-alexa anti-mouse, 594-alexa anti-
rabbit, 488-alexa anti-rabbit, 594-alexa anti-guinea
pig, and 488-alexa anti-guinea pig, 594-alexa anti-
goat, and 488-alexa anti-goat.
Results and discussion
A targeting construct was designed and recombineer-
ing techniques used to introduce one LoxP site within
Fig. 3 Inactivation of Pax4 using the floxed Pax4 allele
recapitulates the phenotype reported for Pax4 knockout (LacZ
knock-in). Immunohistochemical analysis of P1 pancreata
derived from Pax4 fl/? and CMV-Cre::Pax4 fl/LacZ mice for the
pancreatic hormones. Mutant pancreata lack insulin- and
somatostatin-producing delta-cells, while the content of alpha-
cells is proportionally increased. Also, the number of ghrelin-
positive cells is dramatically augmented. These alterations in
hormone expression recapitulate the phenotype previously
described for Pax4 knockout mice (Sosa-Pineda 2004)
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the first intron and a second LoxP site within the sixth
intron of the Pax4 gene. As depicted in Fig. 1A, the
second LoxP site is integrated into the 30end of the
neomycin resistance gene, which is flanked by FRT
sites.
The knockout construct was electroporated into
MPI II ES cells and 2-targeted clones were used to
generate chimeric animals by morulae aggregation.
Mice homozygous for the floxed Pax4 allele were
found normal and fertile. This was true for two mouse
lines derived from two independent targeting events.
Targeting events were confirmed by Southern blot
using 50and 30external probes (Fig. 1B).
Following germ line transmission, the neomycin
cassette was removed by crossing the generated Pax4
animals carrying the floxed allele with transgenic mice
ubiquitously expressing the Flp recombinase (Dym-
ecki 1996). Homozygous mice derived from two
independent Pax4-targeted ES clones for the floxed
allele were also normal and fertile.
To determine whether Pax4 could efficiently be
inactivated, we subsequently crossed the floxed allele-
carrying animals with a transgenic mouse line
expressing the Cre recombinase under the control of
the ubiquitous CMV (Cytomegalovirus) promoter.
This was achieved by crossing previously derived
Pax4?/- heterozygous mice in which the beta-galac-
tosidase coding sequence had been inserted into the
Pax4 locus (Sosa-Pineda et al. 1997), with CMV-Cre
animals, to generate CMV-Cre::Pax4?/- double trans-
genic mice. These were further mated with homozy-
gous Pax4 fl/fl animals. Some of the offspring died at
birth or few days postpartum. Those animals were
genotyped as CMV-Cre::Pax4 fl/LacZ. Using immuno-
histochemistry on pancreas sections of E15.5
embryos, we could demonstrate that in such animals,
Pax4 expression had been abolished, confirming its
complete inactivation (Fig. 2B).
We then asked whether Pax4 inactivation in CMV-
Cre::Pax4 fl/LacZ mice could recapitulate the phenotypic
alterations that were previously described for Pax4
knockout animals using the LacZ knock-in allele (Sosa-
Pineda et al. 1997). Sections from newborn (P1) pancreas
derived from Pax4 fl/? or CMV-Cre::Pax4 fl/LacZ mice
were subjected to immunohistochemistry to assess the
expression of endocrine hormones. As shown in
Fig. 3, insulin- as well as somatostatin-producing
cells were found lacking whereas the alpha-cell
content appeared highly augmented in the islets of
these animals. Moreover, numerous glucagon-
expressing cells were also found positive for the
ghrelin hormone. These findings provide evidence that
the observed phenotype in CMV-Cre::Pax4 fl/LacZ
mice recapitulates the alterations previously described
for the endocrine pancreas of Pax4 knockout animals
(Sosa-Pineda et al. 1997; Wang et al. 2008).
The reported mice carrying the Pax4 floxed allele
therefore represent a powerful tool to study the role of
Pax4 in the adult pancreas, but also in the central
nervous system, in tissues such as in the retina or the
pineal gland (Rath et al. 2009a; Rath et al. 2009b).
Acknowledgments The authors would like to thank S.
Mahsur for excellent ES cell work and U. Franke for the
derivation of germ line chimeras, and C. Heuchel, K. Wetzel for
excellent care of the mice. The highly professional assistance of
T. Schulz is highly acknowledged. The authors were supported
by the Max-Planck Society, the Juvenile Diabetes Research
Foundation, the European Research Council, the INSERM
AVENIR program, the INSERM, the Fondation pour la
Recherche Me´dicale, the Agence Nationale de la Recherche,
the Schlumberger Foundation, the Bundesministerium fu¨r
Bildung und Forschung (BMBF: 01KU0906), Club Isatis, Mr.
and Mrs. Olivier Dorato, and the NIH Beta Cell Biology
Consortium (DK 072495). The authors also thank NG Copeland,
NA Jenkins, and DL Court (Copeland et al. 2001) (http://
recombineering.ncifcrf.gov/Plasmid.asp) for providing us with
plasmids, and bacterial strains for the generation of the targeting
construct by recombineering technique.
Conflict of interest The authors declare that they have no
conflict of interest.
Open Access This article is distributed under the terms of the
Creative Commons Attribution License which permits any use,
distribution, and reproduction in any medium, provided the
original author(s) and the source are credited.
References
Brun T, Franklin I, St-Onge L, Biason-Lauber A, Schoenle EJ,
Wollheim CB, Gauthier BR (2004) The diabetes-linked
transcription factor PAX4 promotes {beta}-cell prolifera-
tion and survival in rat and human islets. J Cell Biol
167(6):1123–1135
Collombat P, Mansouri A, Hecksher-Sorensen J, Serup P, Krull
J, Gradwohl G, Gruss P (2003) Opposing actions of Arx
and Pax4 in endocrine pancreas development. Genes Dev
17(20):2591–2603
Collombat P, Hecksher-Sorensen J, Broccoli V, Krull J, Ponte I,
Mundiger T, Smith J, Gruss P, Serup P, Mansouri A (2005)
The simultaneous loss of Arx and Pax4 genes promotes a
somatostatin-producing cell fate specification at the
expense of the alpha- and beta-cell lineages in the mouse
Transgenic Res (2012) 21:1215–1220 1219
123
endocrine pancreas. Development 132(13):2969–2980.
doi:10.1242/dev.01870
Collombat P, Hecksher-Sorensen J, Serup P, Mansouri A (2006)
Specifying pancreatic endocrine cell fates. Mech Dev
123(7):501–512
Collombat P, Xu X, Ravassard P, Sosa-Pineda B, Dussaud S,
Billestrup N, Madsen OD, Serup P, Heimberg H, Mansouri
A (2009) The ectopic expression of Pax4 in the mouse
pancreas converts progenitor cells into alpha and subse-
quently beta cells. Cell 138(3):449–462. doi:S0092-
8674(09)00639-410.1016/j.cell.2009.05.035
Copeland NG, Jenkins NA, Court DL (2001) Recombineer-
ing: a powerful new tool for mouse functional genomics.
Nat Rev Genet 2(10):769–779. doi:10.1038/35093556
35093556
Dymecki SM (1996) Flp recombinase promotes site-specific
DNA recombination in embryonic stem cells and trans-
genic mice. Proc Natl Acad Sci U S A 93(12):6191–6196
Hu He KH, Lorenzo PI, Brun T, Jimenez Moreno CM, Aeber-
hard D, Vallejo Ortega J, Cornu M, Thorel F, Gjinovci A,
Thorens B, Herrera PL, Meda P, Wollheim CB, Gauthier
BR (2011) In vivo conditional Pax4 overexpression in
mature islet beta-cells prevents stress-induced hypergly-
cemia in mice. Diabetes 60(6):1705–1715. doi:10.2337/
db10-1102
Mansour SL, Thomas KR, Capecchi MR (1988) Disruption of
the proto-oncogene int-2 in mouse embryo-derived stem
cells: a general strategy for targeting mutations to non-
selectable genes. Nature 336(6197):348–352. doi:10.1038/
336348a0
Mansouri A, Hallonet M, Gruss P (1996) Pax genes and their
roles in cell differentiation and development. Curr Opin
Cell Biol 8(6):851–857
Rath MF, Bailey MJ, Kim JS, Coon SL, Klein DC, Moller M
(2009a) Developmental and daily expression of the Pax4
and Pax6 homeobox genes in the rat retina: localization of
Pax4 in photoreceptor cells. J Neurochem 108(1):285–294.
doi:JNC576510.1111/j.1471-4159.2008.05765.x
Rath MF, Bailey MJ, Kim JS, Ho AK, Gaildrat P, Coon SL,
Moller M, Klein DC (2009b) Developmental and diurnal
dynamics of Pax4 expression in the mammalian pineal
gland: nocturnal down-regulation is mediated by adrener-
gic-cyclic adenosine 30,50-monophosphate signaling. Endo-
crinology 150(2):803–811. doi:10.1210/en.2008-0882
Sosa-Pineda B (2004) The gene Pax4 is an essential regulator
of pancreatic beta-cell development. Mol Cells 18(3):
289–294
Sosa-Pineda B, Chowdhury K, Torres M, Oliver G, Gruss P
(1997) The Pax4 gene is essential for differentiation of
insulin-producing beta cells in the mammalian pancreas.
Nature 386(6623):399–402. doi:10.1038/386399a0
Wang Q, Elghazi L, Martin S, Martins I, Srinivasan RS, Geng X,
Sleeman M, Collombat P, Houghton J, Sosa-Pineda B
(2008) Ghrelin is a novel target of Pax4 in endocrine pro-
genitors of the pancreas and duodenum. Dev Dyn
237(1):51–61. doi:10.1002/dvdy.21379
1220 Transgenic Res (2012) 21:1215–1220
123
